Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minyu Wang

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Science Translational Medicine|April 5, 2023
T<sub>STEM</sub>-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical modelsDeborah Meyran, Joe Jiang Zhu, Jeanne Butler, et al.
JCO Precision Oncology|February 9, 2022
Tumor-Infiltrating Lymphocyte Function Predicts Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal CancerJoseph Cherng Huei Kong, Glen Robert Guerra, Rosemary Magdalena Millen, et al.
Nature Immunology|June 8, 2021
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanomaNicolas Jacquelot, Cyril Seillet, Minyu Wang, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Science Translational Medicine|April 5, 2023
T<sub>STEM</sub>-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical modelsDeborah Meyran, Joe Jiang Zhu, Jeanne Butler, et al.
JCO Precision Oncology|February 9, 2022
Tumor-Infiltrating Lymphocyte Function Predicts Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal CancerJoseph Cherng Huei Kong, Glen Robert Guerra, Rosemary Magdalena Millen, et al.
Nature Immunology|June 8, 2021
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanomaNicolas Jacquelot, Cyril Seillet, Minyu Wang, et al.
Pageof 4